BRPI0518543A2 - uma composiÇço para criar um ambiente de medula àssea artificial e usos derivados - Google Patents

uma composiÇço para criar um ambiente de medula àssea artificial e usos derivados

Info

Publication number
BRPI0518543A2
BRPI0518543A2 BRPI0518543-2A BRPI0518543A BRPI0518543A2 BR PI0518543 A2 BRPI0518543 A2 BR PI0518543A2 BR PI0518543 A BRPI0518543 A BR PI0518543A BR PI0518543 A2 BRPI0518543 A2 BR PI0518543A2
Authority
BR
Brazil
Prior art keywords
creating
composition
bone marrow
artificial bone
marrow environment
Prior art date
Application number
BRPI0518543-2A
Other languages
English (en)
Inventor
Vaijayanti Prakash Kale
Lakshmi Charan Padhy
Original Assignee
Nat Ct Cell Sciences
Tata Inst Of Fundamental Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Ct Cell Sciences, Tata Inst Of Fundamental Res filed Critical Nat Ct Cell Sciences
Publication of BRPI0518543A2 publication Critical patent/BRPI0518543A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0669—Bone marrow stromal cells; Whole bone marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/585—Integrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1394—Bone marrow stromal cells; whole marrow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UMA COMPOSIÇçO PARA CRIAR UM AMBIENTE DE MEDULA OSSEA ARTIFICIAL E USOS DERIVADOS. A presente invenção está no domínio da biologia molecular e medicina e se relaciona à composição e métodos in vitro para criação de um ambiente tipo medula ôssea artificial e usos derivados.
BRPI0518543-2A 2005-03-01 2005-07-22 uma composiÇço para criar um ambiente de medula àssea artificial e usos derivados BRPI0518543A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN230MU2005 2005-03-01
PCT/IB2005/002249 WO2006092650A2 (en) 2005-03-01 2005-07-22 A composition for creating an artificial bone -marrow like environment and use thereof

Publications (1)

Publication Number Publication Date
BRPI0518543A2 true BRPI0518543A2 (pt) 2008-11-25

Family

ID=36613442

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518543-2A BRPI0518543A2 (pt) 2005-03-01 2005-07-22 uma composiÇço para criar um ambiente de medula àssea artificial e usos derivados

Country Status (13)

Country Link
US (1) US20080241870A1 (pt)
EP (1) EP1856245A2 (pt)
JP (1) JP5367988B2 (pt)
KR (1) KR101318965B1 (pt)
CN (1) CN101137747B (pt)
AP (1) AP2906A (pt)
AU (1) AU2005328537B2 (pt)
BR (1) BRPI0518543A2 (pt)
CA (1) CA2598936A1 (pt)
IL (1) IL185516A (pt)
MX (1) MX2007010741A (pt)
NZ (1) NZ560813A (pt)
WO (1) WO2006092650A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013020904A1 (en) * 2011-08-05 2013-02-14 Universite D'aix-Marseille Fibrosis susceptibility il22ra2 gene and uses thereof
JP6281850B2 (ja) * 2015-01-28 2018-02-21 公立大学法人横浜市立大学 骨髄細胞凝集体の作製方法
CN105039334B (zh) * 2015-08-26 2017-12-29 山西省农业科学院畜牧兽医研究所 一种鉴别生长性能优异的晋南牛的igf2基因分子标记及其应用
US10815125B2 (en) * 2018-01-05 2020-10-27 Wisconsin Alumni Research Foundation Removable non-conjugated polymers for dispersing carbon nanotubes
CN108359637B (zh) * 2018-02-14 2021-09-28 浙江生创精准医疗科技有限公司 一种宫血干细胞快速扩增的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615414B2 (en) * 1986-04-18 1991-10-03 Marrow-Tech Incorporated Process for replicating bone marrow
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6281408B1 (en) * 1998-02-20 2001-08-28 Thomas Jefferson University Efficient method for production of compound transgenic animals
US6541249B2 (en) * 1999-12-22 2003-04-01 Human Genome Sciences, Inc. Immortalized human stromal cell lines
US6824973B2 (en) * 2000-02-03 2004-11-30 Kirin Beer Kabushiki Kaisha Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide
US20050013804A1 (en) * 2000-09-12 2005-01-20 Yukio Kato Method of culturing mesenchymal stem cells
KR20040023724A (ko) * 2001-08-07 2004-03-18 기린 비루 가부시키가이샤 조혈 간세포의 제조법
WO2003042376A1 (en) * 2001-11-15 2003-05-22 Photothera, Inc. Methods for preparing artificial cartilage

Also Published As

Publication number Publication date
EP1856245A2 (en) 2007-11-21
AU2005328537B2 (en) 2012-02-09
CN101137747A (zh) 2008-03-05
WO2006092650A2 (en) 2006-09-08
CN101137747B (zh) 2013-10-09
IL185516A0 (en) 2008-01-06
US20080241870A1 (en) 2008-10-02
WO2006092650A3 (en) 2007-02-22
NZ560813A (en) 2010-04-30
IL185516A (en) 2015-08-31
AU2005328537A1 (en) 2006-09-08
AP2906A (en) 2014-05-31
MX2007010741A (es) 2008-03-07
KR20080005184A (ko) 2008-01-10
KR101318965B1 (ko) 2013-10-17
CA2598936A1 (en) 2006-09-08
AP2007004164A0 (en) 2007-10-31
JP5367988B2 (ja) 2013-12-11
JP2008531166A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
CY1118038T1 (el) Λυοφιλισμενες φαρμακοτεχνικες μορφες θεραπευτικου πεπτισωματος
FR22C1027I1 (fr) Formulations stabilisant et inhibant la précipitation de compositions immunogènes
CY1114887T1 (el) Συνθεσεις και μεθοδοι παρασκευης συνθεσης
BRPI0821474B8 (pt) formulação farmacêutica líquida estável
ES2552651T3 (es) Composición inyectable de polidesoxirribonucleótido para el tratamiento de enfermedades osteoarticulares
AR121305A2 (es) Proteínas encapsulantes de lípidos neutros modificadas y sus usos
BRPI0715396B8 (pt) método de produção de uma composição para vacina
BR112012016021A8 (pt) Formulações estáveis para liofilização de partículas terapêuticas
CY1113199T1 (el) Σταθεροποιημενες συνθεσεις γλυκοσερεμπροσιδασης
BRPI0611800A2 (pt) formulaÇço estÁvel de anticorpo
ATE528989T1 (de) Kristalline feste rasagilin-base
GT200900292A (es) "inhibidores de cinasa p70 s6"
BRPI0604313A (pt) estrutura polimérica semelhante a dendrìmero para a produção de conjugados de interesse farmacêutico
BRPI0800991A2 (pt) composiÇÕes para uso no escurecimento da pele
CY1112781T1 (el) 2'-φθορο-2'-δεοξυτετραϋδροουριδινες ως αναστολεις αποαμινασης κυτιδινης
CR20110245A (es) Mutantes fgf21 y uso de los mismos.
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
CU23978B1 (es) Composiciones para anticuerpos que se dirigen a la proteína de complemento c5
EP2535058A3 (en) Stabilization of vaccines by lyophilization
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
CR11731A (es) Composiciones y procedimientos para su preparación y uso
BR112012006692A2 (pt) composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
ATE504317T1 (de) Resorbierbares calciumphosphatbasierendes biopolymervernetztes knochenersatzmaterial

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C12N 5/071 (2010.01), C12N 5/077 (2010.01)